Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(anthrax vaccine absorbed )
13 results
  • Anthrax: Where Margins are Merging between Emerging Threats and Bioterrorism. [Journal Article]
    Indian J Dermatol 2017 Sep-Oct; 62(5):456-458Banerjee D, Chakraborty B, Chakraborty B
  • National Institute of Allergy and Infectious Diseases has classified all the emerging infectious diseases agents under three categories. Among Category A priority pathogens comes Bacillus anthracis -the causative agent of Anthrax. It is a gram positive spore bearing bacteria, and the disease is typically associated with grazing animals, and affects the people as a zoonosis. The disease can be cla…
  • Stability and pre-formulation development of a plant-produced anthrax vaccine candidate. [Journal Article]
    Vaccine 2017; 35(41):5463-5470Jones RM, Burke M, … Yusibov V
  • Second generation anthrax vaccines focus on the use of recombinant protective antigen (rPA) to elicit a strong, toxin neutralizing antibody responses in immunized subjects. The main difference between the rPA vaccines compared to the current licensed vaccine, anthrax vaccine absorbed (AVA), is the rPA vaccines are highly purified preparations of only rPA. These second generation rPA vaccines stri…
  • Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. [Journal Article]
    Infect Immun 2016; 84(12):3408-3422Balderas MA, Nguyen CT, … Maresso AW
  • Bacillus anthracis is a sporulating Gram-positive bacterium that is the causative agent of anthrax and a potential weapon of bioterrorism. The U.S.-licensed anthrax vaccine is made from an incompletely characterized culture supernatant of a nonencapsulated, toxigenic strain (anthrax vaccine absorbed [AVA]) whose primary protective component is thought to be protective antigen (PA). AVA is effecti…
  • Vaccines for preventing anthrax. [Review]
    Cochrane Database Syst Rev 2009; (2):CD006403Donegan S, Bellamy R, Gamble CL
  • CONCLUSIONS: One cluster-RCT provides limited evidence that a live-attenuated vaccine is effective in preventing cutaneous anthrax. Vaccines based on anthrax antigens are immunogenic in most vaccinees with few adverse events or reactions. Ongoing randomized controlled trials are investigating the immunogenicity and safety of anthrax vaccines.
  • Anthrax vaccines: Pasteur to the present. [Historical Article]
    Cell Mol Life Sci 2006; 63(19-20):2237-48Scorpio A, Blank TE, … Chabot DJ
  • Anthrax has been a major cause of death in grazing animals and an occasional cause of death in humans for thousands of years. Since the late 1800s there has been an exceptional international history of anthrax vaccine development. Due to animal vaccinations, the rate of infection has dropped dramatically. Anthrax vaccines have progressed from uncharacterized whole-cell vaccines in 1881, to pXO2-n…
New Search Next